ATE548658T1 - Peptidmarker zur diagnose von präeklampsie - Google Patents

Peptidmarker zur diagnose von präeklampsie

Info

Publication number
ATE548658T1
ATE548658T1 AT08705059T AT08705059T ATE548658T1 AT E548658 T1 ATE548658 T1 AT E548658T1 AT 08705059 T AT08705059 T AT 08705059T AT 08705059 T AT08705059 T AT 08705059T AT E548658 T1 ATE548658 T1 AT E548658T1
Authority
AT
Austria
Prior art keywords
preeclampsia
diagnosis
peptide markers
calcyclin
marker
Prior art date
Application number
AT08705059T
Other languages
English (en)
Inventor
Theo Luider
Smitt Petrus Sillevis
Eric Adrianus Petrus Steegers
Original Assignee
Univ Erasmus Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus Medical Ct filed Critical Univ Erasmus Medical Ct
Application granted granted Critical
Publication of ATE548658T1 publication Critical patent/ATE548658T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08705059T 2007-01-12 2008-01-14 Peptidmarker zur diagnose von präeklampsie ATE548658T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2007/050014 WO2008085024A1 (en) 2007-01-12 2007-01-12 Identification and detection of peptides relating to specific disorders
PCT/NL2008/000021 WO2008085036A1 (en) 2007-01-12 2008-01-14 Peptide markers for diagnosis of preeclampsia

Publications (1)

Publication Number Publication Date
ATE548658T1 true ATE548658T1 (de) 2012-03-15

Family

ID=38171286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08705059T ATE548658T1 (de) 2007-01-12 2008-01-14 Peptidmarker zur diagnose von präeklampsie

Country Status (7)

Country Link
US (2) US20100291612A1 (de)
EP (2) EP2118664B1 (de)
AT (1) ATE548658T1 (de)
AU (2) AU2008203968A1 (de)
CA (2) CA2674737A1 (de)
NZ (1) NZ578262A (de)
WO (4) WO2008085024A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2543341T3 (es) 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
US20110247404A1 (en) * 2008-06-25 2011-10-13 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
IT1392551B1 (it) * 2008-11-25 2012-03-09 Bioindustry Park Del Canavese S P A Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica
EA034462B1 (ru) 2009-11-24 2020-02-11 Алетиа Байотерапьютикс Инк. Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований
US9595099B2 (en) * 2010-02-26 2017-03-14 Carolyn M Salafia Automated placental measurement
EP2596132A4 (de) 2010-07-23 2013-12-18 Harvard College Verfahren zur erkennung von anzeichen für krankheiten oder leiden in körperflüssigkeiten
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
KR101449100B1 (ko) 2011-04-21 2014-10-13 가톨릭대학교 산학협력단 신경세포 데브리스 제거용 오스테오폰틴
EP2766726A1 (de) 2011-10-14 2014-08-20 Aarhus Universitet Diagnostischr und prognostische verwendung von prombp-komplexen
US9822170B2 (en) 2012-02-22 2017-11-21 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer
US20150087553A1 (en) * 2012-04-13 2015-03-26 Bioscreening and Diagnostics, LLC Early trimester screening for early- and late-onset preeclampsia
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
MX365418B (es) * 2012-06-26 2019-06-03 Biodesix Inc Metodo por espectros de masa para la seleccion y descarte de pacientes de cancer para el tratamiento con terapias generadoras de respuestas inmunitarias.
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
KR20180029046A (ko) 2015-06-19 2018-03-19 세라 프로그노스틱스 인코포레이티드 조산 예측용 바이오마커 쌍
FR3038984B1 (fr) * 2015-07-15 2020-01-10 Universite de Bordeaux Analyse proteomique de compartiments subcellulaires
WO2018151938A2 (en) * 2017-02-17 2018-08-23 The Methodist Hospital Compositions and methods of determining a level of infection in a subject
EP4530633A3 (de) 2017-08-18 2026-03-25 Sera Prognostics, Inc. Schwangerschaftstaktproteine zur vorhersage des frühstadiums und der geburtszeit
CN111148844A (zh) 2017-09-01 2020-05-12 韦恩生物科技股份公司 鉴定和使用糖肽作为诊断和治疗监测的生物标记物
WO2019202767A1 (ja) * 2018-04-17 2019-10-24 国立大学法人大阪大学 抗線維化剤及び線維症のバイオマーカー

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
US5436132A (en) * 1993-02-13 1995-07-25 Amano Pharmaceutical Co., Ltd. Quantitative determination of tenascin as glioma marker
ITMI20011833A1 (it) * 2001-08-31 2003-03-03 San Raffaele Centro Fond Agenti che regolano la permeabilita' vascolare
CA2519129A1 (en) * 2003-03-18 2004-09-30 Biovision Ag Method for detecting alzheimer's disease and corresponding peptides and detection reagents
WO2005124356A2 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein cbp2 as a marker for colorectal cancer
US8841077B2 (en) * 2006-02-28 2014-09-23 Massachusetts General Hospital Biomarkers for amyotrophic lateral sclerosis and methods using the same

Also Published As

Publication number Publication date
CA2674737A1 (en) 2008-07-17
AU2008203970A1 (en) 2008-07-17
EP2118664B1 (de) 2012-03-07
AU2008203968A1 (en) 2008-07-17
US20100240088A1 (en) 2010-09-23
WO2008085035A1 (en) 2008-07-17
EP2118662A1 (de) 2009-11-18
WO2008085024A1 (en) 2008-07-17
EP2118664A1 (de) 2009-11-18
WO2008085034A1 (en) 2008-07-17
WO2008085036A1 (en) 2008-07-17
NZ578262A (en) 2012-02-24
US20100291612A1 (en) 2010-11-18
CA2674736A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
ATE548658T1 (de) Peptidmarker zur diagnose von präeklampsie
ES2553331T3 (es) Nuevos genes marcadores seleccionables
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
BR112013001752A2 (pt) método de detectar doenças ou condições usando células fagocídicas
UY32698A (es) Marcadores de riesgo para enfermedades cardiovasculares
EP2576839A4 (de) Nukleinsäurenachweis und -quantifizierung durch posthybridisierungs-kennzeichnung und universelle kodierung
EP3636776C0 (de) Verfahren zur analyse von sequenzinformation von nukleinsäuren unter berücksichtigung des gc biases, optional zur diagnose von nukleinsäureanomalien in foeten.
DE602007001585D1 (de) Verfahren zur herstellung von kunstlatex
ATE522488T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
ES2570334T3 (es) Remodelado superficial de proteínas
EP2168728A4 (de) Verfahren zur beurteilung von roboterfehlern
EP2333107A4 (de) Genexpressionsprofil als endometrialer rezeptivitätsmarker
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
DK2140269T3 (da) Proteinsignatur/markører til at detektere adenocarcinom
BRPI0920989A2 (pt) sistema de criação de plano de combinação e dotação de navio, método e programa para o mesmo
ATE514666T1 (de) Verfahren zur herstellung von ethen
EP2306225A4 (de) Verfahren zur erkennung von direktleitungen
ATE495286T1 (de) Verfahren zur hydrolyse von polyphosphorsäure in polyareneazolfasern
WO2013009146A3 (ko) 당뇨망막병증 진단용 마커 및 이의 용도
EP1880029A4 (de) Verbessertes verfahren zur haufenauslaugung von nickelhaltigen oxidischen erzen
EP1928614A4 (de) Verfahren zur diagnose von infektionen
WO2011003623A3 (de) Verfahren und marker zur individuellen prognose und/oder zur individuellen erfassung einer neuropathie
DE112006001625A5 (de) Verfahren zur Erkennung von Fahrspurmarkierungen
EP2650685A3 (de) Verfahren und Kit zur Klassifizierung und Prognose von Wunden